Hugh Griffith

Part of Mativ Holdings, Inc., EdixoMed Ltd. engages in research and development of biotechnology. The private company is based in Edinburgh, UK. The British company was founded by Hugh Stephen Griffith.

MedAnnex Ltd. operates preclinical-stage biotechnology company. It develops approaches to treating autoimmune diseases and other medical conditions. The company was founded by Christopher Barry Wood and Hugh Stephen Griffith in 2009 and is headquartered in Edinburgh, the United Kingdom.

Bioenvision, Inc. engages in the acquisition, development, distribution, and marketing of compounds and technologies for the treatment of cancer. It also develops anti-infective technologies, which includes the OLIGON(R) technology. The company was founded by Christopher B. Wood on August 16, 1996 and is headquartered in New York, NY.

Ernco 200 LTD manufactured pharmaceutical Foscan for cancer treatment, specializes in photodynamic therapy. The company was headquartered in Stirling, the United Kingdom.

Part of Pfizer Inc., Warner Lambert (UK) Ltd. is a manufacturer and wholesaler of pharmaceuticals and over the counter medicines. The private company is based in Eastleigh, UK.

Thirty Holdings Ltd. operates as a holding British company whose subsidiary develops an anti-infective nitric oxide technology platform for the healthcare sector. The company is based in London, UK. The company was founded in 2018 by Christopher Barry Wood.

Alida Capital International Ltd. Provides capital and practical assistance for emerging biopharmaceutical companies. The company was founded by Hugh S. Griffith in 2009 and is headquartered in Edinburgh, the United Kingdom.